Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2008-07-08
2008-07-08
Kam, Chih-Min (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S387100, C514S012200, C536S023100, C536S023500, C435S004000, C435S325000
Reexamination Certificate
active
09575580
ABSTRACT:
This invention discloses endogenous calcineurin inhibitors, Calcipressin, Csp1, Csp2, and Csp3, as shown in SEQ ID Nos: 4-5, or 24. This invention also discloses nucleic acid sequences that can activate or regulate transcription of the CSP family of polypeptides.
REFERENCES:
patent: 4522752 (1985-06-01), Sisto et al.
patent: 4833080 (1989-05-01), Brent et al.
patent: 4868116 (1989-09-01), Morgan et al.
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 5061811 (1991-10-01), Pinori et al.
patent: 5096815 (1992-03-01), Ladner et al.
patent: 5176996 (1993-01-01), Hogan et al.
patent: 5190762 (1993-03-01), Yarosh
patent: 5198346 (1993-03-01), Ladner et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5252348 (1993-10-01), Schreier et al.
patent: 5256775 (1993-10-01), Froehler
patent: 5264564 (1993-11-01), Matteucci
patent: 5283317 (1994-02-01), Saifer et al.
patent: 5288514 (1994-02-01), Ellman
patent: 5359115 (1994-10-01), Campbell et al.
patent: 5362899 (1994-11-01), Campbell
patent: 5459039 (1995-10-01), Modrich et al.
patent: 5498531 (1996-03-01), Jarrell
patent: 5869318 (1999-02-01), Palleja et al.
patent: A43075 (1982-06-01), None
patent: 0259149 (1988-09-01), None
patent: WO8902468 (1989-03-01), None
patent: WO8907136 (1989-08-01), None
patent: WO9002909 (1990-03-01), None
patent: WO9106309 (1991-05-01), None
patent: WO9207573 (1992-05-01), None
patent: WO9209690 (1992-06-01), None
patent: WO9210092 (1992-06-01), None
patent: WO9215694 (1992-09-01), None
patent: WO9320242 (1993-10-01), None
patent: WO9325234 (1993-12-01), None
patent: WO9406920 (1994-03-01), None
patent: WO9408051 (1994-04-01), None
patent: WO9410300 (1994-05-01), None
patent: WO9416101 (1994-07-01), None
Abremski et al., “Bacteriophage P1 Site-Specific Recombination, Purification and Properties of the Cre Recombinase Protein”, J. Biol. Chem. 259: 1509-1514 (1984).
Arkin and Yourvan. “An Algorithm for Protein Engineering: Simulations of Recursive Ensemble Mutagenesis”, PNAS USA 89:7811-7815 (1992).
Armentano et al., “Expression of Human Factor IX In Rabbit Hepatocytes By Retrovirus-Mediated Gene Transfer: Potential for Gene Therapy of Hemophilia B”. PNAS USA 87:6141-6145 (1990).
Ausubel, F.M. et al., “Preparation of a Specific Retrovirus Producer Cell Line”. Current Protocols in Molecular Biology Sections 9.10-9.14 (eds.) Greene Publishing Associates (1989).
Balinderan et al., “Preliminary Crystallization Studies of Calmodulin-Dependent Protein Phosphatase (Calcincurin). From Bovine Brain”. Molecular and Cellular Biochemistry 149/150:127-130 (1995).
Ballas et al., “Liposomes Bearing a Quaternary Ammonium Detergent as an Efficient Vehicle for Functional Transfer of TMV-RNA Into Plant Protoplasts”. Biochim Biophys Acta 939:8-18 (1988).
Banga et al., “Hydrogel-Based lontotherapeutic Delivery Devices for Transidermal Delivery of Peptide/Protein Drugs”. Pharm Res. 10:697-702 (1993).
Barany, “Gentic Disease Detection and DNA Amplification Using Cloned Thermostable Ligase”, PNAS USA 88 189-193 (1991).
Barford D., “Molecular Mechanisms of the Protein Serine/Threonine Phosphatases”, TIBS 21:407-412 (1996).
Bartel et al., “Elimination of False Positives That Arise in Using the Two-Hybrid System”, BioTechniques 14:920-924 (1993).
Bartlett et al., “CAVEAT: A Program to Facilitate the Structure-derived Design of Biologically Active Molecules”, Spec. Publ., Roy Soc. Chem. 78:182-196 (1989).
Bauerfeind et al., Ampothiphysin I Is Associated with Coated Endocytic Intermediatesand Undergoes Stimulation-dependent Dephosphorylation in Nep Terminals Biol. Chem. 272:30984-30992 (1997).
Beals et al., “Nuclear Localization of NF-ATc by a Calcineurin-Dependent. Cyclosporin-Sensitive Intramolecular Interaction”, Genes and Dev. 11:824-834 (1997).
Behr et al, “Efficient Gene Transfer Into Mammalian Primary Endocrine Cells with Lipopolyamine-Coated DNA”, PNAS 86:6982-6986 (1989).
Berkner et al., “Development of Adenovirus Vectors for the Expression of Heterologous Genes”, BioTechniques 6:616-629 (1988).
Benoist et al., “In Vivo Sequence Requirements of the SV40 Early Promoter Region”, Nature 290:304-310 (1981).
Blondelle et al, “Soluble Combinatorial Libraries of Organic. Peptidomimetic and Peptide Diversities”, Trends Anal. Chem 14:83-92 (1995).
Bradley et al., “Embryo-Derived Stem Cells: A Tool for Elucidating the Developmental Genetics of the Mouse”, Current Topics in Devel. Biol. 20:357-371 (1986).
Bradley et al., “Formation of Germ-Line Chimaeras from Embryo-Derived Teratocarcinoma Cells Lines”, Nature 309:255-258 (1984).
Brinster et al., “Regulation of Metallothionein-Thymidine Kinase Fusion Plasmids Injected into Mouse Eggs”, Nature 296:39-42 (1982).
Brinster et al., “Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs”, PNAS 82:4438-4442 (1985).
Brooks et al., CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations, J Comput Chem 4:187-217 (1983).
Buiting et al., “Detection of Aberrant DNA Methylation in Unique Prader-Willi Syndrome Patients and its Diagnostic Implications”, Human Mol. Genet. 3:893-895 (1994).
Burbaum et al. “Understanding Structural Relationships in Proteins of Unsolved Three-Dimensional Structure”, Proteins 7 99-111 (1990).
Chen et al. “‘Analogous’ Organic Synthesis of Small-Compound Libraries: Validation of Combinatorial Chemistry in Small-Molecule Synthesis” JACS 116:2661-2663 (1994).
Clackson et al., “Making Antibody Fragments Using Phage Display Libraries”, Nature 352:624-628 (1991).
Cohen et al., “Emerging Technologies for Sequencing Antisense Oligonucleotides: Capillary Electrophoresis and Mass Spectrometry”, Adv Chromatogr 36:127-162 (1996).
Cole et al., Monoclonal Antibodies and Cancer Therapy. Alan R. Liss. Inc. pp. 77-96 (1985).
Cotton et al., “Reactivity of Cytosine and Thymine in Single-Base-Pair Mismatches with Hydroxylamine and Osmium Tetroxide and Its Application to the Study of Mutations”, PNAS USA 85:4397-4401 (1988).
Cotton, “Current Methods of Mutation Detection”, Mutat Res 285:125-144 (1993).
Crawford et al., “Hamster adapt78 mRNA Is a Down Syndrome Critical Region Homologue That Is Inductible by Oxidative Stress”, Arch. Biochem. Biophys. 342:6-12 (1997).
Cwirla et al., “Peptides On Phage: A Vast Library of Peptides for Identifying Ligands”, PNAS 87:6378-6382 (1990).
Dai et al., “Gene Therapy Via Primary Myoblasts: Long-Term Expression of Factor IX Protein Following Transplantation In Vivo”, PNAS USA 89:10892-10895 (1992).
Dann et al., “Human Renin: A New Class of Inhibitors”, Biochem Biophys Res Commun 134:71-77 (1986).
Danos et al., “Safe and Efficient Generation of Recombinant Retroviruses With Amphotropic ad Ecotropic Host Ranges”, PNAS USA 85:6460-6464 (1988).
Delgrave et al., “Recursive Ensemble Mutagenesis”, Protein Engineering 6(3):327-331 (1993).
Derossi et al., “The Third Helix of the Antennapedia Homcodomain Translocates Through Biological Membranes”, J Biol Chem 269:10444-10450 (1994).
Derossi et al., “Cell Internalization of the Third helix of the Antennapedia Homeodomain Is Receptor-Independent”, J Biol Chem 271:18188-18193 (1996).
DesJarlais et al., “Docking Flexible Ligands to Macromolecular Receptors by Molecular Shape”, J. Med. Chem. 29(1):2149-2153 (1986).
DesJarlais. “Using Shape Complementarity as an Initial Screen in Designing Ligands for a Receptor Binding Site of Known Three-Dimensional Structure”, J. Med Cam 31(4) 722-729 (1988).
Dev et al., “Electrochemotherapy—A Novel Method of Cancer Treatment ”, Cancer Treat Rev. 20:105-115 (1994).
Doctsch
Kayako Kimbara
McKeon Frank
Ryeom Sandra W.
Foley & Hoag LLP
Kam Chih-Min
LandOfFree
Calcipressins: endogenous inhibitors of calcineurin, uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcipressins: endogenous inhibitors of calcineurin, uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcipressins: endogenous inhibitors of calcineurin, uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3921879